Hello,
Welcome back to icliniq.com.
First, I will tell what I would do in such a case based on the evidence. As LN (lymph node) dissection is inadequate, he comes under high-risk stage 2 intestinal cancer. ESMO (European society for medical oncology) guidelines suggest adjuvant doublet treatment (both 5FU or Capecitabine and Oxaliplatin should be given). If FolFox is chosen, then complete twelve cycles every two weeks are needed. If Capox is chosen, then four cycles every three weeks are needed. The choice between CapOx and FolFox is decided after looking at the patient's fitness and co-morbidity. In his case, a medical oncologist has chosen FolFOX because CapOx is a difficult regimen to tolerate. Not all patients can take it, and they may leave the treatment in between. FolFOX is better tolerated than CapOX, especially if the patient's age is above 60 years.
Now, the second oncologist is not a medical oncologist. He is a radiation oncologist, so I would not consider his treatment plan based on the recent knowledge. Only single-agent oral treatment is given for intermediate-risk disease based on MSI (microsatellite instability) status. It is always given for eight cycles and never for four cycles. Before stating single-agent treatment, MSI testing is mandatory. So the final conclusion is
1. Folfox is the preferred option every two weeks for twelve cycles (total six months of t/t).
2. CapOx every three weeks for four cycles (total three months of t/t) is the second option.
3. MSI testing will not give additional information in high-risk cases as we are already treating with doublet treatment. But I would recommend doing it for a different purpose as it can act as a screening test for three percent of cases of hereditary colon cancer.
4. What is the purpose behind doing NGS in stage 2 intestinal cancer?
Treatment is not decided as per NGS, so NGS is not recommended for deciding treatment. If you are doing it as a part of genetic testing for hereditary cancer because of positive family history, you should do it.
5. For hereditary cancer testing, NGS is always done on a blood sample and not on tissue block. I think this should answer your questions. If you have any more queries, you can always revert here. Thank you.